RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
- 1 April 1989
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 47 (4), 606-608
- https://doi.org/10.1097/00007890-198904000-00008